Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Mental Health

Morning light therapy for juvenile depression and severe mood dysregulation: study protocol for a randomized controlled trial

DISCUSSION: In this pilot study, the use of morning bright-light therapy for juvenile depression and severe mood dysregulation shall be evaluated and discussed.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This study protocol describes a planned randomized controlled trial of two weeks of morning bright-light therapy in young people aged 12 to 18 with depression, some with severe mood dysregulation. Participants would receive either active light (10,000 lux) or inactive light (100 lux), with assessments before, after and at three-week follow-up. The authors report no results, as this is a protocol describing a planned pilot study.

Participants
60
Who or what was studied
Young people aged 12 to 18 years with depression, some with additional affective dysregulation symptoms
Limits stated in the abstract
This is a study protocol with no outcome data, and the abstract describes the trial as a pilot study.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

The prevalence of depression in young people is increasing. The predominant co-morbidities of juvenile depression include sleep disturbances and persistent problems with the sleep-wake rhythm, which have shown to influence treatment outcomes negatively. Severe mood dysregulation is another condition that includes depressive symptoms and problems with the sleep-wake rhythm. Patients with severe mood dysregulation show symptoms of depression, reduced need for sleep, and disturbances in circadian functioning which negatively affect both disorder-specific symptoms and daytime functioning. One approach to treating both depression and problems with the sleep-wake rhythm is the use of light therapy. Light therapy is now a standard therapy for ameliorating symptoms of seasonal affective disorder and depression in adults, but has not yet been investigated in children and adolescents. In this trial, the effects of 2 weeks of morning bright-light therapy on juvenile depression and severe mood dysregulation will be evaluated.

Methods/Design

A total of 60 patients with depression, aged between 12 and 18 years, in some cases presenting additional symptoms of affective dysregulation, will be included in this trial. Morning bright-light therapy will be implemented for 2 weeks (10 sessions of 45 minutes each), either with 'active' light (10,000 lux) or 'inactive' light (100 lux). A comprehensive test battery will be conducted before and after treatment and at follow-up 3 weeks later, to assess depression severity, sleep, and attention parameters. Melatonin levels will be measured by assessing the Dim Light Melatonin Onset.

Discussion

In this pilot study, the use of morning bright-light therapy for juvenile depression and severe mood dysregulation shall be evaluated and discussed. TRIALS

Registration

Current Controlled Trials ISRCTN89305231.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Depression, Randomized controlled trial, Lux, Pilot study. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Mental Health

Chronotherapy in the Treatment of Major Depression

Therefore, further research is needed to establish its efficacy more robustly. Moreover, future investigations should explore the potential of digital chronotherapy tools based on ICT, which may offer greater convenience for both patients and healthcare providers.

Review · January 1, 2026 · Kang SG et al.